Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too
Gespeichert in:
| Veröffentlicht in: | British journal of haematology 2006-09, Vol.134 (6), p.645-646 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 646 |
|---|---|
| container_issue | 6 |
| container_start_page | 645 |
| container_title | British journal of haematology |
| container_volume | 134 |
| creator | Canales, Miguel A. Martin, Alejandro Caballero, Dolores Hernandez‐Navarro, Fernando |
| description | |
| doi_str_mv | 10.1111/j.1365-2141.2006.06238.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68789063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68789063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3628-e38ae35c39eb991283ee2e2302eb1646e3268f8f1c3ca67d2d74316efd66279e3</originalsourceid><addsrcrecordid>eNqNkE1OwzAQhS0EgvJzBeQVuwT_pI6DxAIQUBCIDawtN5mASxIH2xXtjiNwRk6CQyvYMpsZad57o_kQwpSkNNbxLKVcjBNGM5oyQkRKBOMyXWyg0e9iE40IIXlCSSZ30K73M0IoJ2O6jXaokLIQNBuh5tGBDi10Ads-GNt5bDrsoNG9hwpbF-fa6TJYt8QTWz2_xnVlPGgPuNfBRKc_weEFcGs68_XxeX55dh9NzyaG4sqCx7AwPuBg7T7aqnXj4WDd99DT1eXjxSS5e7i-uTi7S0oumEyASw18XPICpkVBmeQADBgnDKZUZAI4E7KWNS15qUVesSrPOBVQV0KwvAC-h45Wub2zb3PwQbXGl9A0ugM790rIXBZE8CiUK2HprPfxU9U702q3VJSogbSaqQGoGoCqgbT6Ia0W0Xq4vjGftlD9Gddoo-B0JXg3DSz_HazObyfDxL8BF3qOOA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68789063</pqid></control><display><type>article</type><title>Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too</title><source>MEDLINE</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Canales, Miguel A. ; Martin, Alejandro ; Caballero, Dolores ; Hernandez‐Navarro, Fernando</creator><creatorcontrib>Canales, Miguel A. ; Martin, Alejandro ; Caballero, Dolores ; Hernandez‐Navarro, Fernando</creatorcontrib><identifier>ISSN: 0007-1048</identifier><identifier>EISSN: 1365-2141</identifier><identifier>DOI: 10.1111/j.1365-2141.2006.06238.x</identifier><identifier>PMID: 16889614</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Carmustine - therapeutic use ; Cytarabine - therapeutic use ; Drug Administration Schedule ; Etoposide - therapeutic use ; Hodgkin disease ; Hodgkin Disease - drug therapy ; Humans ; Melphalan - therapeutic use ; mini‐BEAM ; Recurrence ; salvage regimens ; Salvage Therapy</subject><ispartof>British journal of haematology, 2006-09, Vol.134 (6), p.645-646</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3628-e38ae35c39eb991283ee2e2302eb1646e3268f8f1c3ca67d2d74316efd66279e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2141.2006.06238.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2141.2006.06238.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16889614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Canales, Miguel A.</creatorcontrib><creatorcontrib>Martin, Alejandro</creatorcontrib><creatorcontrib>Caballero, Dolores</creatorcontrib><creatorcontrib>Hernandez‐Navarro, Fernando</creatorcontrib><title>Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too</title><title>British journal of haematology</title><addtitle>Br J Haematol</addtitle><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Carmustine - therapeutic use</subject><subject>Cytarabine - therapeutic use</subject><subject>Drug Administration Schedule</subject><subject>Etoposide - therapeutic use</subject><subject>Hodgkin disease</subject><subject>Hodgkin Disease - drug therapy</subject><subject>Humans</subject><subject>Melphalan - therapeutic use</subject><subject>mini‐BEAM</subject><subject>Recurrence</subject><subject>salvage regimens</subject><subject>Salvage Therapy</subject><issn>0007-1048</issn><issn>1365-2141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkE1OwzAQhS0EgvJzBeQVuwT_pI6DxAIQUBCIDawtN5mASxIH2xXtjiNwRk6CQyvYMpsZad57o_kQwpSkNNbxLKVcjBNGM5oyQkRKBOMyXWyg0e9iE40IIXlCSSZ30K73M0IoJ2O6jXaokLIQNBuh5tGBDi10Ads-GNt5bDrsoNG9hwpbF-fa6TJYt8QTWz2_xnVlPGgPuNfBRKc_weEFcGs68_XxeX55dh9NzyaG4sqCx7AwPuBg7T7aqnXj4WDd99DT1eXjxSS5e7i-uTi7S0oumEyASw18XPICpkVBmeQADBgnDKZUZAI4E7KWNS15qUVesSrPOBVQV0KwvAC-h45Wub2zb3PwQbXGl9A0ugM790rIXBZE8CiUK2HprPfxU9U702q3VJSogbSaqQGoGoCqgbT6Ia0W0Xq4vjGftlD9Gddoo-B0JXg3DSz_HazObyfDxL8BF3qOOA</recordid><startdate>200609</startdate><enddate>200609</enddate><creator>Canales, Miguel A.</creator><creator>Martin, Alejandro</creator><creator>Caballero, Dolores</creator><creator>Hernandez‐Navarro, Fernando</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200609</creationdate><title>Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too</title><author>Canales, Miguel A. ; Martin, Alejandro ; Caballero, Dolores ; Hernandez‐Navarro, Fernando</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3628-e38ae35c39eb991283ee2e2302eb1646e3268f8f1c3ca67d2d74316efd66279e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Carmustine - therapeutic use</topic><topic>Cytarabine - therapeutic use</topic><topic>Drug Administration Schedule</topic><topic>Etoposide - therapeutic use</topic><topic>Hodgkin disease</topic><topic>Hodgkin Disease - drug therapy</topic><topic>Humans</topic><topic>Melphalan - therapeutic use</topic><topic>mini‐BEAM</topic><topic>Recurrence</topic><topic>salvage regimens</topic><topic>Salvage Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canales, Miguel A.</creatorcontrib><creatorcontrib>Martin, Alejandro</creatorcontrib><creatorcontrib>Caballero, Dolores</creatorcontrib><creatorcontrib>Hernandez‐Navarro, Fernando</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canales, Miguel A.</au><au>Martin, Alejandro</au><au>Caballero, Dolores</au><au>Hernandez‐Navarro, Fernando</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too</atitle><jtitle>British journal of haematology</jtitle><addtitle>Br J Haematol</addtitle><date>2006-09</date><risdate>2006</risdate><volume>134</volume><issue>6</issue><spage>645</spage><epage>646</epage><pages>645-646</pages><issn>0007-1048</issn><eissn>1365-2141</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16889614</pmid><doi>10.1111/j.1365-2141.2006.06238.x</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-1048 |
| ispartof | British journal of haematology, 2006-09, Vol.134 (6), p.645-646 |
| issn | 0007-1048 1365-2141 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68789063 |
| source | MEDLINE; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals |
| subjects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carmustine - therapeutic use Cytarabine - therapeutic use Drug Administration Schedule Etoposide - therapeutic use Hodgkin disease Hodgkin Disease - drug therapy Humans Melphalan - therapeutic use mini‐BEAM Recurrence salvage regimens Salvage Therapy |
| title | Treatment options in relapsed or refractory Hodgkin disease patients: the mini‐BEAM regimen does exist too |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T09%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20options%20in%20relapsed%20or%20refractory%20Hodgkin%20disease%20patients:%20the%20mini%E2%80%90BEAM%20regimen%20does%20exist%20too&rft.jtitle=British%20journal%20of%20haematology&rft.au=Canales,%20Miguel%20A.&rft.date=2006-09&rft.volume=134&rft.issue=6&rft.spage=645&rft.epage=646&rft.pages=645-646&rft.issn=0007-1048&rft.eissn=1365-2141&rft_id=info:doi/10.1111/j.1365-2141.2006.06238.x&rft_dat=%3Cproquest_cross%3E68789063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68789063&rft_id=info:pmid/16889614&rfr_iscdi=true |